New York A 8253: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Status: REFERRED TO HEALTH (as of 2020-01-08)

State: New York · Session: 2019-2020 · Bill: A 8253

Sponsors: ROSENTHAL D

View New York A 8253 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.